Biotech

All Articles

Jasper dials up dose after colonies actions reoccur rapidly

.Jasper Therapy has disclosed complete feedbacks in 10 of the 12 severe colonies patients that recei...

Transgene's popular cancer cells injection fails midphase examination

.Transgene's curative injection prospect TG4001 has actually flunked a phase 2 solid growth test. Ye...

Upstream swells IPO to $255M as it specifies along with CAMP4

.Upstream Bio possesses puffy its IPO to $255 million as the firm signs up with CAMP4 Rehabs this mo...

Sanofi fails MS study, giving an additional blow to Denali deal

.Sanofi has quit a phase 2 hardship of Denali Therapeutics-partnered oditrasertib in various scleros...

Turnstone lays off 60%, agitates C-suite to extend cash money

.Turnstone Biologics is reducing its own headcount through 60% as well as shaking up its own C-suite...

Gilead gives up on $15M MASH wager after reviewing preclinical information

.In a year that has observed an authorization and a plethora of readouts for metabolic dysfunction-a...

Texas biotech centers cancer cells pact, pins wishes on obesity

.Alaunos Rehabs is actually axing a contract along with Precigen, quiting licensing civil liberties ...

Capricor allotments a lot more records for DMD therapy after launching BLA

.Capricor Rehabs is taking a success lap for their stage 2 Duchenne muscular dystrophy (DMD) trial. ...

FDA areas Kezar lupus test in grip complying with 4 individual fatalities

.The FDA has put Kezar Lifestyle Sciences' lupus test on hold after the biotech hailed 4 deaths duri...

Phase 3 Intellectual Stone trial reaches SMA target, sending stockpile 200%

.A phase 3 trial of Intellectual Stone's spine muscle atrophy (SMA) prospect has actually attacked i...